222 related articles for article (PubMed ID: 23243067)
1. Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy.
Zuern CS; Müller KA; Seizer P; Geisler T; Banya W; Klingel K; Kandolf R; Bauer A; Gawaz M; May AE
Eur J Heart Fail; 2013 Feb; 15(2):176-84. PubMed ID: 23243067
[TBL] [Abstract][Full Text] [Related]
2. CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failure.
Borst O; Schaub M; Walker B; Sauter M; Muenzer P; Gramlich M; Mueller K; Geisler T; Lang F; Klingel K; Kandolf R; Bigalke B; Gawaz M; Zuern CS
Int J Cardiol; 2014 Oct; 176(3):896-903. PubMed ID: 25223819
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcome in patients with suspected myocarditis.
Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M
Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053
[TBL] [Abstract][Full Text] [Related]
4. Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.
Arbustini E; Gavazzi A; Dal Bello B; Morbini P; Campana C; Diegoli M; Grasso M; Fasani R; Banchieri N; Porcu E; Pilotto A; Ponzetta M; Bellini O; Lucreziotti S; Viganò M
G Ital Cardiol; 1997 Mar; 27(3):209-23. PubMed ID: 9199949
[TBL] [Abstract][Full Text] [Related]
5. Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failure undergoing endomyocardial biopsy.
Mueller KA; Tavlaki E; Schneider M; Jorbenadze R; Geisler T; Kandolf R; Gawaz M; Mueller II; Zuern CS
J Card Fail; 2013 Oct; 19(10):678-84. PubMed ID: 24125106
[TBL] [Abstract][Full Text] [Related]
6. Right Ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients.
Nippoldt TB; Edwards WD; Holmes DR; Reeder GS; Hartzler GO; Smith HC
Mayo Clin Proc; 1982 Jul; 57(7):407-18. PubMed ID: 6211578
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery.
Grün S; Schumm J; Greulich S; Wagner A; Schneider S; Bruder O; Kispert EM; Hill S; Ong P; Klingel K; Kandolf R; Sechtem U; Mahrholdt H
J Am Coll Cardiol; 2012 May; 59(18):1604-15. PubMed ID: 22365425
[TBL] [Abstract][Full Text] [Related]
8. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors.
Magnani JW; Danik HJ; Dec GW; DiSalvo TG
Am Heart J; 2006 Feb; 151(2):463-70. PubMed ID: 16442915
[TBL] [Abstract][Full Text] [Related]
9. EMMPRIN and its ligand cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy.
Seizer P; Geisler T; Bigalke B; Schneider M; Klingel K; Kandolf R; Stellos K; Schreieck J; Gawaz M; May AE
Int J Cardiol; 2013 Mar; 163(3):299-304. PubMed ID: 21724278
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and heart rate predict outcome in patients acutely admitted with suspected myocarditis without previous heart failure.
Mahfoud F; Ukena C; Kandolf R; Kindermann M; Böhm M; Kindermann I
J Hypertens; 2012 Jun; 30(6):1217-24. PubMed ID: 22473019
[TBL] [Abstract][Full Text] [Related]
11. Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.
Zuern CS; Walker B; Sauter M; Schaub M; Chatterjee M; Mueller K; Rath D; Vogel S; Tegtmeyer R; Seizer P; Geisler T; Kandolf R; Lang F; Klingel K; Gawaz M; Borst O
Clin Res Cardiol; 2015 Dec; 104(12):1033-43. PubMed ID: 26008895
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.
Caforio AL; Calabrese F; Angelini A; Tona F; Vinci A; Bottaro S; Ramondo A; Carturan E; Iliceto S; Thiene G; Daliento L
Eur Heart J; 2007 Jun; 28(11):1326-33. PubMed ID: 17493945
[TBL] [Abstract][Full Text] [Related]
13. [Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases].
Sinagra G; Maras P; D'Ambrosio A; Gregori D; Bussani R; Silvestri F; Morgera T; Pinamonti B; Salvi A; Alberti E; Di Lenarda A; Lardieri G; Klugmann S; Camerini F
G Ital Cardiol; 1997 Aug; 27(8):758-74. PubMed ID: 9312504
[TBL] [Abstract][Full Text] [Related]
14. [Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].
Kuhn H; Lawrenz T; Beer G
Med Klin (Munich); 2005 Sep; 100(9):553-61. PubMed ID: 16170644
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
[TBL] [Abstract][Full Text] [Related]
16. Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy.
Luciani GB; Montalbano G; Casali G; Mazzucco A
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):478-89. PubMed ID: 10962408
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic contribution of endomyocardial biopsy in suspected latent cardiomyopathy].
Boewer V; Schröder G; Sajkiewicz K; Richter K; Uhlich F; Waigand J
Z Kardiol; 1986 Apr; 75(4):202-10. PubMed ID: 3727659
[TBL] [Abstract][Full Text] [Related]
18. Should endomyocardial biopsy be performed for detection of myocarditis? A decision analytic approach.
Hrobon P; Kuntz KM; Hare JM
J Heart Lung Transplant; 1998 May; 17(5):479-86. PubMed ID: 9628566
[TBL] [Abstract][Full Text] [Related]
19. Outcome predictors in dilated cardiomyopathy or myocarditis.
Kuethe F; Franz M; Jung C; Porrmann C; Reinbothe F; Schlattmann P; Egerer R; Mall G
Eur J Clin Invest; 2017 Jul; 47(7):513-523. PubMed ID: 28556177
[TBL] [Abstract][Full Text] [Related]
20. [Endomyocardial biopsy in cardiomyopathy: when and why?].
Schultheiss HP; Kühl U
Dtsch Med Wochenschr; 2009 Apr; 134(15):769-72. PubMed ID: 19340757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
